Trental Articles
India revises 22 bulk drug prices
2 June 2003
ExonHit says ALS study is on track
24 February 2003
Hoechst/Rhone-Poulenc Merger Looks More Likely
17 November 1998
FH Faulding Reviews "A Year Of Major Change"
3 November 1998
Hoechst Sales Down 18% But HMR Pipeline Strong
19 August 1998
Bad Times Soon Over, Says Hoechst Marion Roussel
12 March 1998
Slovakofarma Gets Local Analysts' OK
27 February 1998
Drug Delivery Sales "To Grow 15% A Year To 2005"
4 February 1998
Teva Enters Marketing Deal With Biovail
18 December 1997
Hoechst Nine-Month Profits Plunge 49%
25 November 1997
Slovakofarma: A Credible Investment Opportunity
30 May 1997
MMD Essential To Hoechst For Leading Pharma Role
3 April 1995
20 Leading US Drugs' Price Increases Slammed
27 March 1995
New Approaches To Treating Colds
24 October 1994
Stability, Consensus And Competition Needed In Germany
3 October 1994
HOECHST-ROUSSEL/KV AGREEMENT
16 May 1994
LIGHT AT THE END OF THE TUNNEL FOR HOECHST?
28 March 1994
ROCHE AIDS DRUG GIVEN BOOST
24 January 1994
HOECHST PHARMA SALES ON THE SLIDE
25 October 1993
THALIDOMIDE PROMISEIN HIV TREATMENT
19 July 1993
PHARMA DIRECTION FOR BRITISH BIO-TECHNOLOGY
19 July 1993
DRUG FIRMS TO WORK TOGETHER ON AIDS R&D
26 April 1993
HOECHST DISSATISFIED WITH 1992 RESULTS
29 March 1993
70% REIMBURSEMENT BACK IN FRANCE?
1 February 1993
POLFA AND HOECHST DEAL
21 December 1992
CHRONIC VENOUS DISEASES OF THE LEG
21 December 1992
J V OPPORTUNITIES IN CHINA
7 September 1992
NEW DRUGS HIGHLIGHTED AT AIDS CONFERENCE
3 August 1992
Showing 1-33 of 33 articles
- 1
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
